We are live on
!
Find out more
ARNA
Arena Pharmaceuticals Inc
ARNA
ARNA
Delisted
ARNA was delisted on the 10th of March, 2022.
125 hedge funds and large institutions have $978M invested in Arena Pharmaceuticals Inc in 2017 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 45 increasing their positions, 40 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
188% more call options, than puts
Call options by funds: $47.9M | Put options by funds: $16.6M
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
34% more capital invested
Capital invested by funds: $731M → $978M (+$247M)
32% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 19
13% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 40
5% more funds holding
Funds holding: 119 → 125 (+6)
Holders
125
Holders Change
+6
Holders Change %
+5.04%
% of All Funds
2.84%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
25
Increased
45
Reduced
40
Closed
19
Calls
$47.9M
Puts
$16.6M
Net Calls
+$31.3M
Net Calls Change
+$13.6M
Top Buyers
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
+$15.3M |
| 2 |
DM
Deerfield Management
New York
|
+$12.8M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$7.98M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$7.45M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$6.3M |
